genome expressing a GPI-anchored CD4-GPI fusion protein on the surface of the cells, we noted the transfer of CD4-GPI to native HeLa cells. Transfer occurred after direct cell contact or exposure to JM88 cell supernatants. The magnitude of contact-mediated CD4-GPI transfer correlated with temperature. Supernatant CD4-GPI also attached to human red blood cells and could be cleaved with phosphatidylinositolspecific phospholipase C. The attached CD4-GPI remained biologically active after transfer and permitted the formation of syncytium when coated HeLa cells were incubated with glycoprotein 160 expressing H9 cells. JM88 cells provide a model for the production, release, and reattachment of CD4-GPI and may furnish insight into a physiologic role of naturally occurring GPI-anchored proteins. This approach may also allow the production of other recombinant GPIanchored proteins for laboratory and clinical investigation.
Proteins covalently linked to GPI represent a large group of molecules with ubiquitous expression in eukaryotes (1) (2) (3) (4) . Their discovery was based on biochemical analyses and demonstrated sensitivity to phosphatidylinositol-specific phospholipase C (PI-PLC) cleavage of the membrane-bound species.
Most of these GPI-linked structures are located at the cell surface with their C-terminal amino acid covalently linked to a glycolipid anchor. The protein, carbohydrate, and lipid components of the structures vary widely among species and tissues making generalizations about their biological function difficult. A growing list of biological functions attributed to these molecules include cell adhesion, nutrient uptake, signal transduction, and complement regulation. Decay-accelerating factor (DAF) is a GPI-linked protein present on the surface of peripheral blood cells and numerous epithelial surfaces (5) . DAF prevents assembly of C3 convertases to protect the host tissue from complement-mediated lysis (6) . In addition, numerous hydrolytic enzymes and proteins with undetermined or pathologic significance like scrapie prion protein have been identified as GPI-linked (7) .
Previous studies have shown the usefulness of a fusion protein consisting of the extracellular domain of CD4 linked to the GPI anchor. HIV efficiently infects human cells having endogenously expressed GPI-anchored CD4 receptors (8, 9 (11) .
We became interested in the CD4-GPI gene as a marker for recombinant adeno-associated virus (rAAV)-mediated gene transfer. Adeno-associated viruses contain a single-stranded DNA genome and belong to the parvovirus family (12) . Their lack of observed pathogenicity, ability to integrate in a sitedirected manner, and broad human tissue tropism in vitro have lead to an interest in using these virions as vehicles for gene therapy. The availability of reagents, the ease of analyses using flow cytometry, and eventual therapeutic strategies were considered in choosing the CD4-GPI marker gene. rAAV particles containing a CD4-GPI fusion gene efficiently transduced and expressed a CD4-GPI molecule on HeLa cells (13) . Those Stocks of the recombinant plasmid and adeno-associated viral vectors, denoted pJM48 and vJM48, were produced and stored as described (13, 16 by ligations of (i) the XhoI-SalI insert of pMClneo poly(A) (Stratagene); (ii) the XhoI-BamHI insert from CMV-CT4D encoding the extracellular domain of CD4 and a DAF-derived signal for the posttranslation attachment of a GPI anchor (17) ; (iii) a BamHI-SalI fragment containing a modified globin poly(A) tail; and (iv) the XhoI-SalI vector fragment of pJM24 containing the rAAV-inverted terminal repeats (18 Syncytium Formation. The assay for syncytium formation using gp160-expressing H9 cells is described elsewhere (19, 20 
RESULTS
Transduction of HeLa cells with the vJM48 rAAV resulted in expression of CD4-GPI on their external cell membranes. The CD4-GPI expression was normally distributed and peaked 44 hr after initial viral exposure. The JM88 cell line shown in Fig.  1 was obtained by sorting the 10% of cells with maximum CD4 fluorescence, followed by clonal selection in G418. The resulting clonal population (JM88) expressed the CD4-GPI receptor at uniformly high levels compared to native HeLa cells ( Fig. 1 A and B) . In contrast to occasional control cells having nonspecific anti-CD4 staining, the entire JM88 population revealed CD4-specific staining in enzyme-based and flow cytometry analyses. A flow cytometry analysis of peripheral blood lymphocytes is shown in Fig. 1C (Fig. 2 A and C) .
The influence of temperature on the transfer of CD4-GPI between cells is shown in Fig. 3 . The cell mixtures were maintained at the indicated temperatures for a total of 25 min before fixation in 4% paraformaldehyde. The To determine whether direct cellular contact was required for CD4-GPI transfer, we analyzed cell-free supernatants for the presence of CD4-GPI able to incorporate into HeLa cell and RBC membranes. Fig. 4 (Fig. 6 A and B) . The incorporation of JM88-released CD4-GPI into native HeLa cell membranes permitted the formation of syncytium in those cells (Fig. 6C) . The process was specific for the presence of CD4-GPI and was blocked by the addition of CD4 antibodies (Fig. 6D) . These results, together with the sensitivity of incorporated CD4-GPI to PI-PLC cleavage (Fig. 3) , provide strong evidence for the ability of CD4-GPI to become an integral, biologically active component of the recipient cell's membrane.
DISCUSSION
We have described a cell line able to release CD4-GPI molecules, which incorporate into recipient cell membranes and retain their biological activity. The associated with a GPI anchor due to an alternately spliced form of endogenous DAF mRNA (22) . Another cell line expressed a CD4-GPI fusion gene but failed to release detectable CD4-GPI of any form (23) . While all the cells express a GPI-anchored CD4 receptor on their plasma membranes, differences in the cell lines include the CD4-GPI-containing genome itself and the absolute level of CD4-GPI expression. These variables may in part explain the novel biological properties of the JM88 cell line.
Contact-mediated transfer of CD4-GPI was demonstrated from high CD4-GPI-expressing clones derived from rAAVtransduced and transfected cell lines (Fig. 2) . In both cases, the transfer occurred after a brief exposure (15-min mix followed by a 10-min low-speed centrifugation). The low level of transfer at 4°C suggests an energy-dependent mechanism. Conversely, the higher level of transfer at 37°C suggests that transfer of GPI-anchored surface proteins between living cells is a rapid process that may be initiated simply by cell-cell contact at physiologic temperatures.
The conclusion that CD4-GPI is released and specifically incorporates into recipient membranes is strongly supported by our data. Incorporation of CD4-GPI into RBCs ruled out the possibility that the CD4-GPI was being expressed from contaminating rAAV or other nucleic acids. The sensitivity of the incorporated CD4-GPI molecules to PI-PLC digestion was specific for anchoring by GPI. The syncytium assay demonstrated that the GPI-anchored CD4-GPI detected by flow cytometry represented integrated, biologically active molecules rather than artifactual or nonspecific binding.
Many questions remain, including the ease with which other cell lines that release biologically active, GPI-linked proteins can be created and the physical nature, stability, and metabolism of released and membrane reincorporated CD4-GPI. The CD4-GPI particles in the cell supernatants could represent shed membrane, vesicular, or micelle forms. Alternatively, the supernatant CD4-GPI may have been transported by a component of the bovine serum medium supplement (24) . To precisely understand the molecular mechanism of GPI-linked intercellular transfer, cell culture in defined medium preparations, eventual purification, and precise biochemical identification of the supernatant CD4-GPI will be required.
Our in vitro model for the release and reincorporation of GPI-linked proteins to lipid bilayers may enhance the interpretation of other reports. These include the finding that schistosomes in contact with plasma evade the alternative complement pathway by incorporating functional host DAF into their membranes (25) . GPI anchor-bearing alkaline phosphatase has been detected in human serum (26) , and alkaline phosphatase found in calf intestinal lumen hypothetically concentrates the enzyme by GPI incorporation into chyme (27) . Scrapie prion protein is thought to originate and replicate from endocytosis and conversion of a GPI-anchored membrane isoform (28 
